![Craig Hopkinson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Craig Hopkinson
Chief Tech/Sci/R&D Officer at
ALKERMES PLC
Net worth: 3 M $ as of 2026-08-30
Profile
Craig C. Hopkinson is Chief Medical Officer & EVP-Research & Development at Alkermes Plc. In the past Dr. Hopkinson occupied the position of Senior VP & Head-Global Medical Affairs at Vertex Pharmaceuticals, Inc. and President-Eisai Value Maximization Systems at Eisai, Inc. Dr. Hopkinson received an undergraduate degree from the University of the Free State.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-08-31 | 65,389 ( 0.04% ) | 3 M $ | 2026-08-30 |
Craig Hopkinson active positions
| Companies | Position | Start |
|---|---|---|
| ALKERMES PLC | Chief Tech/Sci/R&D Officer | 2017-05-29 |
Former positions of Craig Hopkinson
| Companies | Position | End |
|---|---|---|
| ALBIREO PHARMA, INC. | Director/Board Member | 2023-03-01 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Chief Tech/Sci/R&D Officer | 2019-12-31 |
| VERTEX PHARMACEUTICALS INCORPORATED | Chief Tech/Sci/R&D Officer | 2017-04-30 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | President | 2012-11-30 |
Training of Craig Hopkinson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
58
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
Alkermes Plc
 Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
University of the Free State
 University of the Free State Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
- Stock Market
- Insiders
- Craig Hopkinson
